Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2019-nCoV (COVID-19)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04894409
What this trial is testing

Evaluation of Silver Nanoparticles for the Prevention of COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Cluster de Bioeconomia de Baja California, A.C 231
Testing effectiveness (Phase 2)Study completedNCT06305793
What this trial is testing

RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)

Who this might be right for
Long COVIDLong Coronavirus Disease 2019 (Covid19)Long Covid-19
Kanecia Obie Zimmerman 200
Not applicableStudy completedNCT04398264
What this trial is testing

Characteristics of COVID-19 Infection Among PREGnant Women

Who this might be right for
Corona Virus InfectionPregnancy Related
Inova Health Care Services 650
Not applicableUnknownNCT04452942
What this trial is testing

Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
EicOsis Human Health Inc. 30
Not applicableStudy completedNCT04760990
What this trial is testing

Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.

Who this might be right for
Multiple SclerosisCOVID-19 (Severe Coronavirus Disease 2019)
University Hospital, Basel, Switzerland 1,181
Testing effectiveness (Phase 2)Ended earlyNCT04778059
What this trial is testing

Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19

Who this might be right for
2019 Novel Coronavirus InfectionCOVID-19 Virus InfectionSARS Coronavirus 2 Infection+3 more
US Biotest, Inc. 21
Testing effectiveness (Phase 2)Study completedNCT04402866
What this trial is testing

TD-0903 for ALI Associated With COVID-19

Who this might be right for
Acute Lung Injury (ALI) Associated With COVID-19Lung Inflammation Associated With COVID-19
Theravance Biopharma 235
Not applicableUnknownNCT04292327
What this trial is testing

Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus

Who this might be right for
Pneumonia Caused by Human Coronavirus
Fujian Provincial Hospital 400
Testing effectiveness (Phase 2)UnknownNCT05047783
What this trial is testing

Masitinib in Patients With Symptomatic Mild to Moderate COVID-19

Who this might be right for
Covid19SARS-CoV2 InfectionCoronavirus Disease 2019
AB Science 78
Large-scale testing (Phase 3)UnknownNCT04353180
What this trial is testing

Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)

Who this might be right for
COVID19
Kafrelsheikh University 100,000
Early research (Phase 1)WithdrawnNCT04464460
What this trial is testing

Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults

Who this might be right for
Coronavirus Disease
Takeda
Early research (Phase 1)Study completedNCT05656508
What this trial is testing

ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

Who this might be right for
COVID-19 Vaccine
Laboratorio Pablo Cassara S.R.L. 80
Testing effectiveness (Phase 2)Study completedNCT07134725
What this trial is testing

Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG

Who this might be right for
COVID - 19
Federal University of Minas Gerais 432
Not applicableEnded earlyNCT06703190
What this trial is testing

Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine

Who this might be right for
COVID-19
Pfizer 1
Early research (Phase 1)Study completedNCT04646044
What this trial is testing

A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19

Who this might be right for
Covid-19Coronavirus Disease 2019
Nektar Therapeutics 30
Large-scale testing (Phase 3)UnknownNCT05091411
What this trial is testing

Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 1,680
Large-scale testing (Phase 3)Study completedNCT04380519
What this trial is testing

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

Who this might be right for
COVID-19
R-Pharm International, LLC 372
Not applicableWithdrawnNCT04251767
What this trial is testing

Washed Microbiota Transplantation for Patients With 2019-nCoV Infection

Who this might be right for
COVID-19 Complicated With Refractory Intestinal Infections
The Second Hospital of Nanjing Medical University
Not applicableStudy completedNCT05104411
What this trial is testing

Rehabilitation in Severely Ill Inpatients With COVID-19

Who this might be right for
COVID-19
Seoul National University Bundang Hospital 37
Not applicableStudy completedNCT04430322
What this trial is testing

Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study

Who this might be right for
COVID
Centre Hospitalier Régional Metz-Thionville 1,045
Next Page